Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
Add more filters










Publication year range
1.
J Immunol ; 165(1): 518-27, 2000 Jul 01.
Article in English | MEDLINE | ID: mdl-10861091

ABSTRACT

Human PBMC engraft in mice homozygous for the severe combined immunodeficiency (Prkdcscid) mutation (Hu-PBL-scid mice). Hu-PBL-NOD-scid mice generate 5- to 10-fold higher levels of human cells than do Hu-PBL-C.B-17-scid mice, and Hu-PBL-NOD-scid beta2-microglobulin-null (NOD-scid-B2mnull) mice support even higher levels of engraftment, particularly CD4+ T cells. The basis for increased engraftment of human PBMC and the functional capabilities of these cells in NOD-scid and NOD-scid-B2mnull mice are unknown. We now report that human cell proliferation in NOD-scid mice increased after in vivo depletion of NK cells. Human cell engraftment depended on CD4+ cells and required CD40-CD154 interaction, but engrafted CD4+ cells rapidly became nonresponsive to anti-CD3 Ab stimulation. Depletion of human CD8+ cells led to increased human CD4+ and CD20+ cell engraftment and increased levels of human Ig. We further document that Hu-PBL-NOD-scid mice are resistant to development of human EBV-related lymphoproliferative disorders. These disorders, however, develop rapidly following depletion of human CD8+ cells and are prevented by re-engraftment of CD8+ T cells. These data demonstrate that 1) murine NK cells regulate human cell engraftment in scid recipients; 2) human CD4+ cells are required for human CD8+ cell engraftment; and 3) once engrafted, human CD8+ cells regulate human CD4+ and CD20+ cell expansion, Ig levels, and outgrowth of EBV-related lymphoproliferative disorders. We propose that the Hu-PBL-NOD-scid model is suitable for the in vivo analysis of immunoregulatory interactions between human CD4+ and CD8+ cells.


Subject(s)
Herpesvirus 4, Human/immunology , Leukocytes, Mononuclear/transplantation , Lymphoproliferative Disorders/genetics , Lymphoproliferative Disorders/immunology , Severe Combined Immunodeficiency/genetics , Severe Combined Immunodeficiency/immunology , Adoptive Transfer , Animals , Antigen-Presenting Cells/immunology , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , CD40 Antigens/metabolism , CD40 Ligand , CD8-Positive T-Lymphocytes/immunology , Cell Division/genetics , Cell Division/immunology , Cell Line, Transformed , Clonal Anergy/genetics , Epstein-Barr Virus Infections/genetics , Epstein-Barr Virus Infections/immunology , Humans , Immunity, Innate/genetics , Immunophenotyping , Interphase/genetics , Interphase/immunology , Killer Cells, Natural/immunology , Ligands , Lymphocyte Activation/genetics , Lymphocyte Depletion , Lymphoproliferative Disorders/prevention & control , Lymphoproliferative Disorders/virology , Membrane Glycoproteins/metabolism , Mice , Mice, Inbred NOD , Mice, SCID , Peritoneal Cavity/pathology , Severe Combined Immunodeficiency/virology , T-Lymphocytes/immunology , T-Lymphocytes, Cytotoxic/transplantation
2.
J Immunol ; 164(5): 2496-507, 2000 Mar 01.
Article in English | MEDLINE | ID: mdl-10679087

ABSTRACT

Development of a small animal model for the in vivo study of human immunity and infectious disease remains an important goal, particularly for investigations of HIV vaccine development. NOD/Lt mice homozygous for the severe combined immunodeficiency (Prkdcscid) mutation readily support engraftment with high levels of human hematolymphoid cells. However, NOD/LtSz-scid mice are highly radiosensitive, have short life spans, and a small number develop functional lymphocytes with age. To overcome these limitations, we have backcrossed the null allele of the recombination-activating gene (Rag1) for 10 generations onto the NOD/LtSz strain background. Mice deficient in RAG1 activity are unable to initiate V(D)J recombination in Ig and TCR genes and lack functional T and B lymphocytes. NOD/LtSz-Rag1null mice have an increased mean life span compared with NOD/LtSz-scid mice due to a later onset of lymphoma development, are radioresistant, and lack serum Ig throughout life. NOD/LtSz-Rag1null mice were devoid of mature T or B cells. Cytotoxic assays demonstrated low NK cell activity. NOD/LtSz-Rag1null mice supported high levels of engraftment with human lymphoid cells and human hemopoietic stem cells. The engrafted human T cells were readily infected with HIV. Finally, NOD/LtSz-Rag1null recipients of adoptively transferred spleen cells from diabetic NOD/Lt+/+ mice rapidly developed diabetes. These data demonstrate the advantages of NOD/LtSz-Rag1null mice as a radiation and lymphoma-resistant model for long-term analyses of engrafted human hematolymphoid cells or diabetogenic NOD lymphoid cells.


Subject(s)
Adoptive Transfer , Diabetes Mellitus, Type 1/immunology , Genes, RAG-1/immunology , HIV Infections/immunology , Hematopoietic Stem Cell Transplantation , Immunologic Deficiency Syndromes/genetics , Radiation Tolerance/immunology , T-Lymphocytes/transplantation , Adoptive Transfer/methods , Aging/genetics , Aging/immunology , Animals , Diabetes Mellitus, Type 1/genetics , Disease Models, Animal , Erythrocyte Count , Female , Fetal Blood/cytology , Fetal Blood/immunology , HIV Infections/genetics , Hematopoietic Stem Cell Transplantation/methods , Humans , Immunoglobulins/blood , Immunologic Deficiency Syndromes/immunology , Immunologic Deficiency Syndromes/pathology , Immunologic Deficiency Syndromes/physiopathology , Immunophenotyping , Killer Cells, Natural/immunology , Leukocyte Count , Leukocytes, Mononuclear/transplantation , Longevity , Lymphoid Tissue/pathology , Lymphoma/genetics , Lymphoma/immunology , Lymphoma/pathology , Lymphoma/physiopathology , Male , Mice , Mice, Inbred C57BL , Mice, Inbred NOD , Mice, Knockout , Mice, SCID , Poly I-C/pharmacology , Radiation Tolerance/genetics , Spleen/cytology , Spleen/immunology , Spleen/transplantation
3.
Stem Cells ; 16(3): 166-77, 1998.
Article in English | MEDLINE | ID: mdl-9617892

ABSTRACT

The discovery of the severe combined immunodeficiency (scid) mouse mutation has provided a tool for establishment of small animal models as hosts for the in vivo analysis of normal and malignant human pluripotent hemopoietic stem cells. Intravenous injection of irradiated scid mice with human bone marrow, cord blood, or G-CSF cytokine-mobilized peripheral blood mononuclear cells, all rich in human hemopoietic stem cell activity, results in the engraftment of a human hemopoietic system in the murine recipient. This model has been used to identify a pluripotent stem cell, termed "scid-repopulating cell" (SRC) that is more primitive than any of the hemopoietic stem cell populations identified using the currently available in vitro methodology. In this review, we describe the development and use of this model system, termed Hu-SRC-SCID, and summarize the discoveries that have resulted from the investigation of human stem cells in this model. Finally, we detail the recent extension of the original Hu-SRC-SCID model system based on the C.B-17-scid mouse as the murine host to the Hu-SRC-NOD-SCID model based on the NOD-scid mouse as the host. The engraftment of human stem cells in the Hu-SRC-NOD-SCID model is enhanced over that observed in the Hu-SRC-SCID model and results in exceptionally high levels of human hemopoietic cells in the murine recipient. Future directions to further improve the Hu-SRC-NOD-SCID model system and the potential utility of this model in the preclinical and diagnostic arenas of hematology and oncology are discussed.


Subject(s)
Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells/physiology , Mice, SCID , Transplantation, Heterologous , Animals , Hematopoietic Stem Cells/cytology , Hemolysis , Humans , Leukemia-Lymphoma, Adult T-Cell/pathology , Mice , Models, Biological
4.
Cell Transplant ; 7(1): 25-35, 1998.
Article in English | MEDLINE | ID: mdl-9489760

ABSTRACT

Antibodies to the ligand for CD40 (CD154) have been shown to exert profound effects on the development of cell-mediated immune responses in mice. The present study shows that an antibody to human CD154 (hCD40L) inhibits in vivo Tetanus toxoid (TT) specific secondary antibody responses in hu-PBL-scid mice, as well as the expansion of xenoreactive human T cells in the scid mice. A possible cause for the reduced expansion of xenoreactive, human T cells, was the decreased expression of murine B7.1 and B7.2 caused by the administration of anti-hCD40L. Therefore, it may be that defective maturation of murine antigen-presenting cells impeded the priming and expansion of human xenoreactive T cells.


Subject(s)
CD40 Antigens/metabolism , Membrane Glycoproteins/antagonists & inhibitors , T-Lymphocytes/immunology , T-Lymphocytes/transplantation , Adult , Animals , Antibodies, Monoclonal , Antigens, CD/metabolism , B-Lymphocytes/cytology , B-Lymphocytes/immunology , B7-1 Antigen/metabolism , B7-2 Antigen , CD40 Ligand , Cell Differentiation , Cell Transplantation , Graft Survival/immunology , Humans , Ligands , Lymphocyte Activation , Membrane Glycoproteins/metabolism , Mice , Mice, SCID , Tetanus Toxoid/immunology , Transplantation, Heterologous
5.
J Immunol ; 158(8): 3578-86, 1997 Apr 15.
Article in English | MEDLINE | ID: mdl-9103418

ABSTRACT

Genetic crosses produced NOD/LtSz mice doubly homozygous for the severe combined immunodeficiency (scid) mutation and the beta2m (B2m) null allele. Both NOD/LtSz-scid/scid and NOD/LtSz-scid/scid B2m(null) mice lacked mature lymphocytes and serum Ig. However, homozygosity for the B2m(null) allele also resulted in the absence of MHC class I expression, loss of NK cell activity, accumulation of iron in the liver, and rapid clearance of human IgG1. NOD/LtSz-scid/scid B2m(null) mice supported markedly elevated levels of human T cell engraftment, compared with NOD/LtSz-scid/scid control animals, following injection with human PBMC. The increased engraftment was associated with a major increase in the number of human CD4+ T cells. Following injection with 20 million human PBMC, levels of human CD4+ T cells in the peripheral blood and spleen of NOD/ LtSz-scid/scid B2m(null) mice were 6- to 7-fold higher than those in NOD/LtSz-scid/scid mice and >50-fold higher than those in C.B-17-scid/scid mice. The resulting normalization of CD4+/CD8+ ratios in NOD/LtSz-scid/scid B2m(null) mice is in sharp contrast to that observed in NOD/LtSz-scid/scid mice or in C.B-17-scid/scid mice. Circulating human IgG was cleared 6-fold more rapidly in NOD/LtSz-scid/scid B2m(null) mice than in NOD/LtSz-scid/scid mice. This rapid IgG clearance suggested a failure of the engrafted human lymphoid cells to maintain high circulating levels of human IgG. The higher levels of human CD4+ T cells and the normalization of the CD4:CD8 ratio that are observed in human PBMC-engrafted NOD/LtSz-scid/scid B2m(null) mice suggest that this system may be an excellent model for studies of HIV pathogenesis.


Subject(s)
CD4-Positive T-Lymphocytes/transplantation , Graft Survival , beta 2-Microglobulin/deficiency , Animals , CD4-CD8 Ratio , CD4-Positive T-Lymphocytes/immunology , Crosses, Genetic , Humans , Mice , Mice, Inbred NOD , Mice, SCID
6.
Cell Immunol ; 171(2): 186-99, 1996 Aug 01.
Article in English | MEDLINE | ID: mdl-8806787

ABSTRACT

The severe combined immunodeficiency (scid) mutation was backcrossed onto the C57BL/6J strain background in order to study the role of natural killer (NK) cells in rejection of normal and malignant human lymphohematopoietic cells. C57BL/6J-scid/scid mice showed severe loss of mature T and B cells accompanied by increased percentages of NK1.1+ cells and myeloid cells. Although little or no serum immunoglobulin was detectable prior to 2 months of age, all mice tested had circulating immunoglobulin by 7.5 months of age. C57BL/6J-scid/scid mice had markedly elevated levels of both hemolytic complement activity and NK cell activity compared with C57BL/6J - (+/+) controls. Weekly injections with anti-NK1.1 antibody resulted in elimination of NK cell activity in C57BL/6J-scid/scid mice throughout 8 weeks of treatment. Although human CEM-C7 T lymphoblastoid tumor cells grew slowly in unmanipulated C57BL/6J-scid/scid mice, anti-NK1.1 treatment resulted in increased growth accompanied by metastasis of human lymphoma cells to the brain, liver, and kidney. In contrast to T lymphoblastoid tumor cells, nonmalignant human peripheral blood mononuclear cells engrafted at low levels in anti-NK1.1-treated as well as in unmanipulated C57BL/6-scid/scid mice. Backcrossing of the beige (bgJ) mutation onto the C57BL/6-scid/scid genetic stock caused decreased NK cell activity accompanied by granulocyte defects. C57BL/6-scid/scid bgJ)/bgJ) mice showed metastasis of human CEM-C7 cells to the brain and other organs but supported only low levels of engraftment with human peripheral blood mononuclear cells. These results demonstrate that NK cells, in the absence of an adaptive immune system, function in resistance to metastasis of human lymphomas and suggest that innate immune factors in addition to NK cell function mediate resistance to engraftment of normal human peripheral blood leukocytes.


Subject(s)
Killer Cells, Natural/immunology , Leukemia, T-Cell/immunology , Neoplasm Metastasis/immunology , T-Lymphocytes/immunology , Animals , Antibodies, Monoclonal , Blood Cell Count , Cell Division , Female , Flow Cytometry , Graft Rejection/immunology , Hemolysis , Humans , Immunoglobulins/blood , Intracellular Signaling Peptides and Proteins , Leukemia, T-Cell/pathology , Leukocytes, Mononuclear/immunology , Male , Mice , Mice, Inbred C57BL , Mice, SCID , Neoplasm Transplantation , Neutrophils/immunology , Proteins/genetics , Proteins/immunology , Spleen/cytology , Spleen/immunology , T-Lymphocytes/cytology , T-Lymphocytes/transplantation , Tumor Cells, Cultured , Vesicular Transport Proteins
7.
Biol Blood Marrow Transplant ; 2(1): 15-23, 1996 Feb.
Article in English | MEDLINE | ID: mdl-9078350

ABSTRACT

Human lymphoematopoietic stem cells engraft in irradiated immunodeficient mice that are homozygous for the severe combined immunodeficiency (scid) mutation. Engraftment levels in C.B-17-scid/scid mice, however, have been low and transient, decreasing the utility of this model for investigation of the development potential and function of human stem cells. In the present study, we have used NOD/LtSz-scid/scid mice as recipients and human cord blood as a source of donor stem cells. Our results demonstrate that NOD/LtSz-scid/scid mice support approximately fivefold higher levels of human stem cell marrow engraftment than do C.B-17-scid/scid mice. Human CD34+ cells are present in the marrow of recipient mice, and the engrafted cells readily peripheralize to the circulation of the host. Terminal differentiation of the stem and progenitor cells into mature progeny is limited. Using a multiple-day injection protocol developed in mice, which allows engraftment of stem cells between congenic mice in the absence of irradiation preconditioning, we observed high levels of human cell engraftment in unirradiated NOD/LtSz-scid/scid recipients after three or five consecutive-day injections. These results demonstrate that NOD/LtSz-scid/scid mice support high levels of human stem cell engraftment and that xenogeneic lymphohematopoietic stem cells can engraft in unirradiated hosts without the need for ablative reconditioning. This model will be useful for the in vivo investigation of human stem cells and for the preclinical analysis of human stem cells for transplantation.


Subject(s)
Fetal Tissue Transplantation , Graft Survival , Hematopoietic Stem Cell Transplantation , Animals , Female , Humans , Mice , Mice, Inbred NOD , Mice, SCID , Pregnancy , Transplantation, Heterologous , Whole-Body Irradiation
8.
In Vivo ; 10(1): 33-7, 1996.
Article in English | MEDLINE | ID: mdl-8726809

ABSTRACT

Human cord blood (HuCB) can colonize a murine fetal thymus organ culture (FTOC) and generate phenotypically immature (CD4+ CD8+) and mature (CD4+ CD8-; CD4- CD8+) T cells. We have used this model system to demonstrate that the human T cells that develop in this culture system can be infected with HIV-1. A cytopathic and non-cytopathic patient isolate of HIV-1 were used to infect FTOC established using C.B-17 or NOD/LtSz.scid/scid strain fetal thymic lobes colonized with HuCB. At 13-15 days after infection, FTOC were placed in co-culture with human PHA-blasts. These co-cultures demonstrated the presence of replicating HIV-1. Few human CD45+ cells were detectable in the thymic lobes that were infected with HIV-1, while high numbers of human CD45+ T cells were present in the uninfected cultures. These results demonstrate the cytopathicity of HIV-1 on human T lymphocytes that have developed in a HuCB colonized FTOC system.


Subject(s)
HIV-1/pathogenicity , T-Lymphocytes/virology , Animals , CD4 Antigens/immunology , CD8 Antigens/immunology , HIV-1/isolation & purification , Humans , Leukocyte Common Antigens/immunology , Mice , Mice, SCID , Organ Culture Techniques , T-Lymphocytes/immunology , Thymus Gland/cytology , Thymus Gland/immunology , Thymus Gland/virology
9.
Diabetes ; 44(12): 1392-8, 1995 Dec.
Article in English | MEDLINE | ID: mdl-7589844

ABSTRACT

When used as hosts in passive transfer experiments, a stock of NOD/Lt mice congenic for the severe combined immunodeficiency (scid) mutation have provided great insight to the contributions of various T-cell populations in the pathogenesis of autoimmune insulin-dependent diabetes mellitus (IDDM). Moreover, NOD-scid mice support higher levels of human lymphohematopoietic cell growth than the C.B-17-scid strain in which the mutation originated. However, the ability to perform long-term lymphohematopoietic repopulation studies in the NOD-scid stock has been limited by the fact that most of these mice develop lethal thymic lymphomas beginning at 20 weeks of age. These thymic lymphomas are characterized by activation and subsequent genomic reintegrations of Emv30, an endogenous murine ecotropic retrovirus unique to the NOD genome. To test the role of this endogenous retrovirus in thymomagenesis, we produced a stock of Emv30null NOD-scid mice by congenic replacement of the proximal end of chromosome 11 with genetic material derived from the closely related NOR/Lt strain. Thymic lymphomas still initiate in Emv30null NOD-scid females, but their rate of progression is significantly retarded since the frequency of tumors weighing between 170 and 910 mg at 25 weeks of age was reduced to 20.8% vs. 76.2% in Emv30% segregants. The thymic lymphomas that did develop in Emv30null NOD-scid mice were not characterized by a compensatory increase in mink cell focus-forming proviral integrations, which initiate thymomagenesis in other susceptible mouse strains. Significantly, the ability of standard NOD T-cells to transfer IDDM to the Emv30null NOD-scid stock was not impaired.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Autoimmune Diseases/immunology , Diabetes Mellitus, Type 1/immunology , Hematopoietic Stem Cells/cytology , Lymphocytes/cytology , Animals , Cell Division , Female , Humans , Immunization, Passive , Lymphoma/genetics , Male , Mice , Mice, Inbred NOD , Mice, SCID , Spleen/cytology , T-Lymphocytes/transplantation , Thymus Neoplasms/genetics
10.
J Infect Dis ; 172(4): 974-82, 1995 Oct.
Article in English | MEDLINE | ID: mdl-7561218

ABSTRACT

Inbred C.B-17-scid/scid mice accept human peripheral blood mononuclear cell (PBMC) xenografts and are susceptible to human immunodeficiency virus type 1 (HIV-1) infection, but low levels of PBMC engraftment impede use of this system in HIV research. This report describes the effect of host strain background on human PBMC engraftment and HIV infectivity in scid mice. Back-crossing the scid mutation to the NOD/Lt strain (designated NOD/LtSz-scid/scid) increased the percentage of engrafted human PBMC in recipient spleens by 5- to 10-fold compared with that in C.B-17-scid/scid stock. Four weeks after human PBMC-injected mice were infected with HIV-1, 79% of NOD/LtSz-scid/scid spleens harbored replicating virus compared with only 39% of spleens in C.B-17-scid/scid mice. The NOD/LtSz-scid/scid mouse may provide a useful small animal model for studies of HIV-1.


Subject(s)
HIV Infections , HIV-1/growth & development , Leukocytes, Mononuclear/transplantation , Transplantation, Heterologous , Animals , DNA, Viral/genetics , DNA, Viral/isolation & purification , Disease Susceptibility , Flow Cytometry , Humans , Lymph Nodes/cytology , Lymphocyte Depletion , Mice , Mice, Inbred NOD , Mice, SCID , Polymerase Chain Reaction , Species Specificity , Spleen/cytology , Thymus Gland/cytology
11.
Am J Pathol ; 146(4): 888-902, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7717456

ABSTRACT

T and B lymphocyte-deficient mice homozygous for the severe combined immunodeficiency (SCID) mutation can be immunologically engrafted with human lymphocytes. However, low levels of human peripheral blood mononuclear cell engraftment are commonly observed, impeding full use of this model. We now demonstrate that strain background in mice homozygous for the scid mutation is a strong determinant of levels of human lymphocyte engraftment. NOD/LtSz-scid/scid mice support higher levels of engraftment of both human spleen and peripheral blood mononuclear cells than do C.B-17-scid/scid mice. We observed, using human spleen cell injected scid mice, 1), high levels of engraftment of the host peripheral lymphoid tissues with human CD45+ (leukocytes), CD3+ (T cells), CD4+ (helper/inducer), and CD8+ (suppressor/cytotoxic) lymphoid cells for up to 24 weeks in NOD/LtSz-scid/scid mice; 2), migration of high numbers of human lymphocytes to peripheral lymphoid and nonlymphoid organs in NOD/LtSz-scid/scid, but not in C.B-17-scid/scid mice; 3), higher levels of serum immunoglobulin of human origin in NOD/LtSz-scid/scid mice than in C.B-17-scid/scid mice; 4), histological lesions characteristic of human anti-mouse xenoreactivity in NOD/LtSz-scid/scid mice; and 5), human origin antibodies against filarial antigens after engraftment with native human spleen cells. The use of NOD/LtSz-scid/scid mice as recipients to achieve significantly enhanced human lymphopoietic cell engraftment will now enable human immunity to be more easily studied in animal models.


Subject(s)
Cell Transplantation , Graft Survival/immunology , Spleen/cytology , Transplantation, Heterologous/immunology , Animals , Antibodies, Helminth/immunology , Antigens, CD/immunology , Blotting, Western , Brugia malayi/immunology , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry , Gonadal Steroid Hormones/physiology , Humans , Leukocytes, Mononuclear/transplantation , Male , Mice , Mice, Inbred NOD , Mice, SCID
12.
AIDS Res Hum Retroviruses ; 10(4): 395-403, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8068417

ABSTRACT

A detailed, longitudinal study was undertaken to investigate the immunological and virological features of an individual with hemophilia infected with human immunodeficiency virus type-1 (HIV-1) for 10 years without disease. Methods applied to serial samples of peripheral blood included Western blot analysis, neutralizing antibody assays, antibody-dependent cell-mediated cytotoxicity (ADCC) titration, HIV-1 specific cytotoxic T lymphocyte (CTL) assays, viral cultures, and PCR with sequence analysis of viral regulatory genes. Strong antibody responses against HIV-1 antigens as measured by Western blot and ADCC assays have persisted throughout infection. Repeated attempts to isolate HIV-1 using sensitive culture techniques and to demonstrate viremia with standard PCR methods have failed. Using the "booster" PCR technique, a period of viremia in peripheral blood mononuclear cells was demonstrated. Concurrent with detection of circulating virus, titers of neutralizing antibodies and circulating HIV-1-specific CTLs became measurable. Sequencing studies of a portion of the viral genome showed no significant abnormalities of the regulatory genes. In this individual, the combination of low viral load in the peripheral blood and a strong, responsive immune system is associated with long-term, disease-free coexistence with HIV-1 infection.


Subject(s)
HIV Infections/immunology , HIV-1 , Antibody-Dependent Cell Cytotoxicity , DNA, Viral/genetics , DNA, Viral/isolation & purification , HIV Antibodies/blood , HIV Infections/complications , HIV Infections/microbiology , HIV-1/genetics , HIV-1/isolation & purification , Hemophilia A/complications , Humans , Male , Middle Aged , Phenotype , Polymerase Chain Reaction , T-Lymphocytes, Cytotoxic/immunology , Time Factors , Viremia/microbiology , Virus Cultivation , Virus Replication
13.
AIDS Res Hum Retroviruses ; 10(3): 279-84, 1994 Mar.
Article in English | MEDLINE | ID: mdl-8018388

ABSTRACT

Replication of the IIIB strain of human immunodeficiency virus type 1 (HIV-1IIIB) in CB.17 scid/scid mice reconstituted with human peripheral blood lymphocytes (Hu-PBL-SCID) was investigated. Hu-PBL-SCID mice could be infected, in a dose-dependent manner, when HIV-1IIIB was injected intraperitoneally. Replication-competent HIV-1 could be recovered from spleen, peripheral blood, bone marrow, thymus, lymph node, and peritoneal cavity, indicating the ability of the infection to spread to human tissue throughout the chimeric animals. HIV-1 infection was quantitated using p24 determination, end-point dilution culture, and polymerase chain reaction amplification. The level of HIV-1 replication in Hu-PBL-SCID mice was found to approximate the level reported in human infection. No HIV-1-specific immune response was generated to this infection, but nonspecific immune activation did occur, as also reported in human infection. Similarities therefore exist between HIV-1 infection of humans and Hu-PBL-SCID mice, which makes the latter an in vivo model in which to study HIV-1 replication.


Subject(s)
HIV Infections/microbiology , HIV-1/physiology , Lymphocyte Transfusion , Virus Replication , Animals , HIV-1/isolation & purification , Humans , Mice , Mice, SCID , Models, Biological , Polymerase Chain Reaction , Transplantation, Heterologous
14.
J Virol ; 67(12): 7406-13, 1993 Dec.
Article in English | MEDLINE | ID: mdl-7693971

ABSTRACT

Epstein-Barr virus (EBV) recombinants with specifically mutated BCRF1 genes were constructed and compared with wild-type BCRF1 recombinants derived in parallel for the ability to initiate and maintain latent infection and growth transformation in primary human B lymphocytes. A stop codon insertion after codon 116 of the 170-codon BCRF1 open reading frame or deletion of the entire gene had no effect on latent infection, B-lymphocyte proliferation into long-term lymphoblastoid cell lines (LCLs), or virus replication. LCLs infected with the stop codon recombinant were indistinguishable from wild-type recombinant-infected LCLs in tumorigenicity in SCID mice. However, mutant BCRF1 recombinant-infected cells differed from wild-type recombinant-infected cells in their inability to block gamma interferon release in cultures of permissively infected LCLs incubated with autologous human peripheral blood mononuclear cells. This is the first functional assay for BCRF1 expression from the EBV genome. BCRF1 probably plays a key role in modulating the specific and nonspecific host responses to EBV infection.


Subject(s)
Genes, Viral , Herpesvirus 4, Human/genetics , Interleukin-10 , Mutation , Recombination, Genetic , Viral Proteins/genetics , Animals , B-Lymphocytes/microbiology , Cell Transformation, Viral , Clone Cells , Gene Deletion , Humans , Interferons/biosynthesis , Leukocytes, Mononuclear , Mice , Mice, SCID , Neoplasms, Experimental/microbiology , RNA, Viral/biosynthesis , Virus Latency
15.
J Infect Dis ; 168(3): 630-40, 1993 Sep.
Article in English | MEDLINE | ID: mdl-8354904

ABSTRACT

Immune reconstitutions (hu-PBL-SCID mice) resulting from adoptive transfer of human peripheral blood mononuclear cells into 1800 C.B-17 scid-/scid-mice were characterized. Over 90% of reconstitutions were successful as evidenced by human immunoglobulin production. Variability was noted with donor, cell number, and cell type. Human cells (T lymphocytes, few B cells) could be recovered by 5 days after engraftment. High levels of soluble CD8 and interleukin-2 receptors were detected in sera of hu-PBL-SCID mice. Cells recovered from 17 mice proliferated in response to antigens to which the donor had been primed; responses to nonboosted antigen also increased in some animals. After reconstitution, lymphocytes were found in the spleen and lymph nodes without full restoration of normal architecture. The hu-PBL-SCID mouse shows promise as a model system for a variety of immunologic studies. The inherent variation in the system must be minimized for appropriate use of the model.


Subject(s)
Immune System/immunology , Leukocytes, Mononuclear/transplantation , Mice, SCID/immunology , Age Factors , Animals , Blood Cells/cytology , CD3 Complex/analysis , CD4 Antigens/analysis , CD8 Antigens/analysis , Humans , Immunoglobulins/analysis , Mice , Models, Biological , Peritoneal Cavity/cytology , Phenotype , Receptors, Interleukin-2/analysis , Species Specificity , Specific Pathogen-Free Organisms , Spleen/cytology , Time Factors , Transplantation, Heterologous
16.
J Infect Dis ; 167(5): 1008-13, 1993 May.
Article in English | MEDLINE | ID: mdl-8486935

ABSTRACT

Thirty-three infants born to human immunodeficiency virus type 1 (HIV-1)-seropositive women were evaluated from birth using plasma and peripheral blood mononuclear cell (PBMC) cultures, polymerase chain reaction, and serum p24 antigen assays. Five children were identified as infected. Evidence of infection was found in cord blood and subsequent samples from 2 infected children, suggesting in utero infection. Virologic studies on cord blood and early neonatal specimens from the 3 other infected children were negative but became positive by 8 weeks of age, suggesting either intrapartum transmission or sequestration of virus with subsequent detection. An increase in blood (plasma and PBMC) virus titers consistent with primary viremia was observed in 4 infants between 3 and 16 weeks of age. Blood virus titers subsequently declined in the absence of antiretroviral therapy and in the absence of activated HIV-1-specific cytotoxic T lymphocyte responses or broadly neutralizing antibodies. Confirmation of these results in larger studies may be helpful in the design of clinical trials to interrupt vertical transmission or to modify the course of infection.


Subject(s)
HIV Infections/immunology , HIV-1/immunology , Viremia/immunology , Adult , Cells, Cultured , Female , HIV Antibodies/blood , HIV Infections/microbiology , HIV Infections/transmission , Humans , Infant , Infant, Newborn , Phenotype , Polymerase Chain Reaction , Prospective Studies , T-Lymphocyte Subsets/immunology
18.
J Immunol ; 145(6): 1929-33, 1990 Sep 15.
Article in English | MEDLINE | ID: mdl-2167913

ABSTRACT

Immunologic changes produced by Herpesvirus sylvilagus infection of cottontail rabbits were investigated to evaluate this virus infection system as an animal model for EBV infection in humans. H. sylvilagus neutralizing antibodies appeared as early as 7 days after infection, peaked 2 to 4 wk postinfection and decreased to low levels by 8 to 10 wk postinfection. Complement-dependent antibodies mediating the protection of in vitro infection of monocytes and Con A-stimulated lymphoblasts with H. sylvilagus were observed as were complement-dependent cytotoxic antibodies against H. sylvilagus-infected cells. No cytolytic activity was present in sera taken either before or 3 days after infection; cytolysis was first observed 7 days after infection. The development of cytolytic antibodies appeared to be biphasic during an infection course of 12 to 16 wk. In vivo induction of a primary cytotoxic lymphocyte response to H. sylvilagus was also investigated. Splenic lymphocytes from infected animals lysed H. sylvilagus-infected skin fibroblasts; however, similar activity was not observed when PBMC or mesenteric lymph node lymphocytes were used as effector cells. H. sylvilagus-infected autologous skin fibroblasts were preferentially lysed as compared to heterologous skin fibroblasts. This virus-specific cytotoxic activity appeared 5 days postinfection and peaked 7 days postinfection. By 28 days postinfection, only low levels of cytotoxic activity were detected in spleen cells. Herpesvirus sylvilagus infection of cottontail rabbits provides an animal model for the study of lymphoproliferative disorders induced by herpesviruses.


Subject(s)
Herpesviridae Infections/immunology , Herpesviridae/immunology , Animals , Antibodies, Viral/biosynthesis , Antibody Formation , Complement System Proteins/physiology , Cytotoxicity, Immunologic , Immunity, Cellular , Major Histocompatibility Complex , Neutralization Tests , Rabbits , T-Lymphocytes, Cytotoxic/immunology
19.
J Virol ; 63(9): 3601-11, 1989 Sep.
Article in English | MEDLINE | ID: mdl-2547988

ABSTRACT

Herpesvirus saimiri is a primate tumor virus that induces acute T-cell lymphomas in New World monkeys. Strains of this virus have been previously classified into three groups on the basis of extreme DNA variability of the rightmost region of unique L-DNA. To compare the oncogenic potentials of various strains, we inoculated New Zealand White rabbits with viruses representing groups A, B, and C of herpesvirus saimiri. The results showed that a group C strain were highly oncogenic in New Zealand White rabbits; however, group A or B viruses were not oncogenic in these rabbits. Analysis of DNAs of tumor tissues and lymphoid cell lines established from tumors showed that the viral genome exists in circular episomal form. To identify which part of the genome of the group C strain is responsible for the highly oncogenic phenotype, group B-C recombinant strains were constructed by an efficient drug selection technique. Two group B recombinant strains in which the right-end 9.2 kilobase pairs of unique DNA is replaced by group C virus DNA were oncogenic in rabbits, indicating that the rightmost sequences contribute to the oncogenic properties of the group C strain. Oncogenicity of herpesvirus saimiri has been traditionally evaluated in New World monkeys; infection of rabbits with group C strain 484-77 offers a much more accessible animal model to study the mechanism of oncogenicity of this virus.


Subject(s)
DNA, Viral/analysis , Herpesvirus 2, Saimiriine/pathogenicity , Lymphoma/etiology , Animals , DNA, Circular/analysis , Genes, Viral , Herpesvirus 2, Saimiriine/genetics , Rabbits , Recombination, Genetic , Tumor Cells, Cultured
20.
Am J Pathol ; 133(3): 639-47, 1988 Dec.
Article in English | MEDLINE | ID: mdl-2849303

ABSTRACT

Experimental infection with Herpesvirus sylvilagus produces clinical and histopathologic changes in its natural host, the cottontail rabbit (Sylvilagus floridanus), similar to those observed in humans acutely infected with Epstein-Barr virus (EBV). Twenty-seven seronegative cottontail rabbits were infected with Herpesvirus sylvilagus and all developed antibodies within 10 days. Neutralizing antibody was detected as early as 7 days after infection. Virus was isolated from blood mononuclear cells, spleen, bone marrow, thymus, lymph nodes, kidneys, lung, and liver as early as 3 days after infection. Infected animals showed leucocytosis, monocytosis, and lymphocytosis with the appearance of atypical lymphocytes. Peripheral blood abnormalities peaked at 10-14 days after infection, and returned to normal by 28 days after infection, with the exception of atypical lymphocytosis that persisted in some animals for more than 2 years after experimental infection. More severe histopathologic changes were seen in virus-infected juvenile rabbits than adult rabbits; these changes included viral myocarditis, interstitial pneumonia, and lymphocytic myositis. Reactive hyperplasia and subsequent lymphocytic depletion of spleen and lymph nodes were reminiscent of that seen in virus-associated hemophagocytosis syndrome. Prominent lymphoid hyperplasia of many nonlymphoid organs, most notably the kidney and lungs, was observed. The development of these lymphoproliferative lesions and other lymphoid changes during H. sylvilagus infection suggest that this system may be a model to study similar lesions induced by EBV infection in humans.


Subject(s)
Disease Models, Animal , Herpesviridae Infections/pathology , Rabbits , Animals , Antibodies, Viral/biosynthesis , DNA, Viral/analysis , Herpesviridae/genetics , Herpesviridae/immunology , Herpesviridae Infections/immunology , Herpesviridae Infections/microbiology , Hyperplasia , Inflammation , Kidney/pathology , Lung/pathology , Lymph Nodes/pathology , Lymphoid Tissue/pathology , Muscles/pathology , Myocardium/pathology , Necrosis , Spleen/pathology , Thymus Gland/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...